MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MRUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Merus (MRUS) Ownership - Who owns Merus?

Merus NV is a clinical-stage immuno-oncology company... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.83B
P/E Ratio
N/A
Total Cash
635.93M
Projected Growth
N/A
Total Debt
12.32M
Revenue
56.61M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
8.38
Total Debt/Equity
N/A
Revenue/Share
0.80 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MRUS
A.I. Advisor
published General Information

General Information

a developer of therapeutics for cancer treatment

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
Uppsalalaan 17
Phone
+31 302538800
Employees
229
Web
https://www.merus.nl